ZA966969B - Medicaments - Google Patents

Medicaments

Info

Publication number
ZA966969B
ZA966969B ZA966969A ZA966969A ZA966969B ZA 966969 B ZA966969 B ZA 966969B ZA 966969 A ZA966969 A ZA 966969A ZA 966969 A ZA966969 A ZA 966969A ZA 966969 B ZA966969 B ZA 966969B
Authority
ZA
South Africa
Prior art keywords
medicaments
Prior art date
Application number
ZA966969A
Inventor
Hugh Brownlie Mcdade
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ZA966969B publication Critical patent/ZA966969B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA966969A 1995-08-19 1996-08-16 Medicaments ZA966969B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9517022.1A GB9517022D0 (en) 1995-08-19 1995-08-19 Medicaments

Publications (1)

Publication Number Publication Date
ZA966969B true ZA966969B (en) 1997-03-24

Family

ID=10779487

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA966969A ZA966969B (en) 1995-08-19 1996-08-16 Medicaments

Country Status (6)

Country Link
EP (1) EP0844878A1 (en)
JP (1) JPH11512083A (en)
AU (1) AU6924796A (en)
GB (1) GB9517022D0 (en)
WO (1) WO1997006804A1 (en)
ZA (1) ZA966969B (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9605293D0 (en) * 1996-03-13 1996-05-15 Glaxo Group Ltd Medicaments
US6767991B1 (en) 1997-08-11 2004-07-27 Boehringer Ingelheim (Canada) Ltd. Hepatitis C inhibitor peptides
HUP0100100A3 (en) * 1997-08-11 2001-12-28 Boehringer Ingelheim Ca Ltd Hepatitis c inhibitor peptide analogues, pharmaceutical compositions comprising thereof and their use
KR100965488B1 (en) * 1998-02-25 2010-06-24 에모리 유니버시티 2'-Fluoronucleosides
US6323180B1 (en) 1998-08-10 2001-11-27 Boehringer Ingelheim (Canada) Ltd Hepatitis C inhibitor tri-peptides
US6608027B1 (en) 1999-04-06 2003-08-19 Boehringer Ingelheim (Canada) Ltd Macrocyclic peptides active against the hepatitis C virus
GB9909154D0 (en) * 1999-04-22 1999-06-16 Nippon Glaxo Limited Pharmaceutical formulation
WO2001007027A2 (en) * 1999-07-22 2001-02-01 Vertex Pharmaceuticals Incorporated Pyrimidine derivatives for the treatment of viral diseases
US7244721B2 (en) 2000-07-21 2007-07-17 Schering Corporation Peptides as NS3-serine protease inhibitors of hepatitis C virus
CA2410662C (en) 2000-07-21 2012-09-18 Schering Corporation Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
PL365695A1 (en) 2000-07-21 2005-01-10 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
ES2402597T3 (en) * 2000-10-18 2013-05-07 Gilead Pharmasset Llc Modified nucleosides for the treatment of viral infections and abnormal cell proliferation
PL213029B1 (en) 2002-05-20 2012-12-31 Bristol Myers Squibb Co Substituted cycloalkyl p1' hepatitis c virus inhibitors
PL211889B1 (en) 2002-05-20 2012-07-31 Bristol Myers Squibb Co Heterocyclicsulfonamide hepatitis c virus inhibitors
MY140680A (en) 2002-05-20 2010-01-15 Bristol Myers Squibb Co Hepatitis c virus inhibitors
US7041698B2 (en) 2002-05-20 2006-05-09 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
MXPA05012545A (en) 2003-05-21 2006-02-08 Boehringer Ingelheim Int Hepatitis c inhibitor compounds.
US20050058044A1 (en) * 2003-09-12 2005-03-17 Koegler John M. Optical disk modified for speed and orientation tracking
CN1856502A (en) 2003-09-22 2006-11-01 贝林格尔.英格海姆国际有限公司 Macrocyclic peptides active against the hepatitis c virus
JP4584260B2 (en) 2003-10-14 2010-11-17 インターミューン・インコーポレーテッド Macrocyclic carboxylic acids and acylsulfonamides as HCV replication inhibitors
US7132504B2 (en) 2003-11-12 2006-11-07 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
US7309708B2 (en) 2003-11-20 2007-12-18 Birstol-Myers Squibb Company Hepatitis C virus inhibitors
US7135462B2 (en) 2003-11-20 2006-11-14 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
ATE495185T1 (en) 2004-01-21 2011-01-15 Boehringer Ingelheim Int MACROCYCLIC PEPTIDES ACTIVE AGAINST HEPATITIS C VIRUS
ATE512971T1 (en) 2004-07-20 2011-07-15 Boehringer Ingelheim Int PEPTIDE ANALOGUES AS HEPATITIS C INHIBITORS
UY29016A1 (en) 2004-07-20 2006-02-24 Boehringer Ingelheim Int ANALOGS OF INHIBITING DIPEPTIDES OF HEPATITIS C
EA019888B1 (en) 2005-07-25 2014-07-30 Интермьюн, Инк. Intermediate compound for making macrocyclic inhibitors of hepatitis c virus replication and method of synthesis thereof
DE602006019323D1 (en) 2005-10-11 2011-02-10 Intermune Inc COMPOUNDS AND METHOD FOR INHIBITING THE REPLICATION OF THE HEPATITIS C VIRUS
CN101511375B (en) * 2005-12-02 2012-09-05 耶鲁大学 Methods of treating cancer and other conditions or disease states using l-cytosine nucleoside analogs
AR067442A1 (en) 2007-06-29 2009-10-14 Gilead Sciences Inc ANTIVIRAL COMPOUNDS
AP2009005073A0 (en) 2007-06-29 2009-12-31 Gilead Sciences Inc Antiviral compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int Pharmaceutical compositions containing cis-4-amino-1(hydroxymethyl-1,3-oxathiolan-5-yl)-1H-pyrimid-2-one nucleoside or its derivatives

Also Published As

Publication number Publication date
JPH11512083A (en) 1999-10-19
EP0844878A1 (en) 1998-06-03
WO1997006804A1 (en) 1997-02-27
GB9517022D0 (en) 1995-10-25
AU6924796A (en) 1997-03-12

Similar Documents

Publication Publication Date Title
HUP9801151A3 (en) Long-shelf-life medicaments
GB9517022D0 (en) Medicaments
GR3032245T3 (en) Medicaments
GB9406573D0 (en) Medicaments
GB9420784D0 (en) Medicaments
GB9526392D0 (en) Medicaments
GB9503850D0 (en) Medicaments
GB9418530D0 (en) Medicaments
GB9411052D0 (en) Medicaments
GB9421133D0 (en) Medicaments
GB9416365D0 (en) Medicaments
GB9517021D0 (en) Medicaments
GB9523453D0 (en) Medicaments
GB9514723D0 (en) Medicaments
GB9504153D0 (en) Medicaments
GB9506122D0 (en) Medicaments
GB9524173D0 (en) Medicaments
GB9515628D0 (en) Medicaments
IL127776A0 (en) Medicaments
GB9521208D0 (en) Medicaments
GB9519585D0 (en) Medicaments
GB9519021D0 (en) Medicaments
GB9519029D0 (en) Medicaments
GB9424013D0 (en) Medicaments
EP0790829A4 (en) Medicaments